CPC-023 Brain Imaging, Alzheimer’s
Dr. Faulhaber begins a three-part series on non-oncologic brain imaging. He summarizes the CMS approval process, which has led to the evaluation of Alzheimer’s Dementia (AD) with PET. He also examines how imaging can help aid in the early diagnosis and in distinguishing between AD and mild cognitive impairment. Early detection and treatment to delay the onset of AD could potentially have a significant impact on the cost of care, which is currently estimated at 150 billion dollars.